Form 4 Filing for Anika Therapeutics, Inc.

This filing details a Form 4 submission for Anika Therapeutics, Inc. by Sheryl L. Conley, who is a director. On June 18, 2026, Ms. Conley acquired 10,402 shares of Common Stock. The transaction code "A" indicates an acquisition, and the price per share was $0.00. Following this transaction, Ms. Conley holds 52,970 shares. The acquired shares are noted as restricted stock units (RSUs) which vest in full on the earlier of the 2027 annual meeting or June 18, 2027. This acquisition is marked as direct ownership.